Stay updated on STK-012 in Solid Tumors with Pembrolizumab Clinical Trial

Sign up to get notified when there's something new on the STK-012 in Solid Tumors with Pembrolizumab Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the STK-012 in Solid Tumors with Pembrolizumab Clinical Trial page

  1. Check
    5 days ago
    No Change Detected
  2. Check
    12 days ago
    No Change Detected
  3. Check
    19 days ago
    Change Detected
    Summary
    The history section now surfaces a 'Find contact information' item and shows the latest revision tag 'Revision: v3.7.0'. This replaces the prior 'Find Contact Information' label and the older 'Revision: v3.6.6'.
    Difference
    0.2%
    Check dated 2026-09-20T20:37:53.000Z thumbnail image
  4. Check
    40 days ago
    Change Detected
    Summary
    The record history shows Revision: v3.6.6, indicating a new revision of the study record was posted, replacing the previous v3.6.5.
    Difference
    0.1%
    Check dated 2026-08-30T22:37:06.000Z thumbnail image
  5. Check
    61 days ago
    Change Detected
    Summary
    The study history's revision label was updated from v3.6.4 to v3.6.5, indicating a new platform revision for the page.
    Difference
    0.1%
    Check dated 2026-08-09T17:09:42.000Z thumbnail image
  6. Check
    76 days ago
    Change Detected
    Summary
    On 2026-07-21, the page adds new sections for Study Status and Study Identification and updates the revision to v3.6.4. The earlier v3.6.3 revision was removed on 2026-07-10.
    Difference
    0.5%
    Check dated 2026-07-25T07:45:42.000Z thumbnail image
  7. Check
    91 days ago
    Change Detected
    Summary
    New sections for Study Status and Study Identification were added to the study history on 2026-07-10 and 2026-07-08, representing updates to the trial’s current status and identifying details; a deletion was recorded on 2026-06-29.
    Difference
    0.4%
    Check dated 2026-07-10T22:52:15.000Z thumbnail image
  8. Check
    98 days ago
    Change Detected
    Summary
    This update adds several core study sections (Contacts/Locations, Eligibility, Outcome Measures, Arms and Interventions, Study Description, Sponsor/Collaborators, Study Status) and introduces Revision: v3.6.3 (version 14) to the record, reflecting expanded study detail.
    Difference
    1.0%
    Check dated 2026-07-03T20:09:39.000Z thumbnail image

Stay in the know with updates to STK-012 in Solid Tumors with Pembrolizumab Clinical Trial

Enter your email address, and we'll notify you when there's something new on the STK-012 in Solid Tumors with Pembrolizumab Clinical Trial page.